Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyhomeotic homolog 1 pseudogene 1, abbreviated as PHC1P1, is a pseudogene that corresponds to the polyhomeotic homolog 1 (PHC1) gene in humans[1]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they usually arise from gene duplication or retrotransposition events and typically do not encode active proteins[1]. PHC1P1 itself does not produce a functional protein and plays no direct biological or therapeutic role. It should not be confused with the functional PHC1 protein, which is a constituent of the Polycomb group (PcG) repressive complex 1 (PRC1) and has roles in chromatin remodeling and gene repression, especially during development[3]. In summary, PHC1P1 is not a therapeutic target, receptor, or protein of therapeutic interest. It is possible that confusion between PHC1P1 and PHC1 could lead to misclassification in databases or target lists, but the pseudogene itself lacks the properties of a druggable or functional molecular target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyhomeotic homolog 1 pseudogene 1 (PHC1P1).